Yongjian S. Wu
Zhuhai, 519000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Retraction of TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis.
Journal: The Journal of clinical investigation
Published: September 01, 2026
Soluble TREM2 engages cell-surface nucleolin to drive vascular permeability and malignant ascites in ovarian cancer.
Journal: EMBO molecular medicine
Published: November 10, 2025
Engineered nanovesicles as a DC vaccine to enhance the antitumor efficacy of CAR-T cells against solid tumors.
Journal: Journal of nanobiotechnology
Published: September 28, 2025
TREM2 Drives Neutrophil Extracellular Traps-Induced Dendritic Cell Maturation and Contributes to Lupus Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2025
Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 07, 2025
The role of TREM2 in sepsis. Reply.
Journal: The Journal of clinical investigation
Published: February 17, 2025
Platelet membrane-coated nanoparticles inhibit platelet activation and neutrophil extracellular traps formation in acute lung injury.
Journal: Journal of translational medicine
Published: February 11, 2025
Type 2 diabetes impairs macrophage antimicrobial capability and increases susceptibility to sepsis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 09, 2025
Inflammatory CD11c+ B Cells Induced by the TREM2 Signal Accelerate Sepsis Development.
Journal: The Journal of infectious diseases
Published: September 25, 2024
Disulfiram-loaded nanovesicles hydrogel promotes healing of diabetic wound.
Journal: Journal of translational medicine
Published: August 30, 2024
Last Updated: 09/26/2026